Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. JCAP
JCAP logo

JCAP Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Jefferson Capital Inc (JCAP) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
17.340
1 Day change
-0.40%
52 Week Range
23.800
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Jefferson Capital Inc (JCAP) does not currently present a strong buy opportunity for a beginner investor with a long-term strategy. While the company has positive medium-term prospects and analyst support, the absence of significant trading signals, lack of recent news catalysts, and neutral insider and hedge fund sentiment suggest that waiting for a more favorable entry point or additional positive developments would be prudent.

Technical Analysis

The MACD is positive and expanding (0.254), indicating bullish momentum. RSI is at 70.268, which is neutral but approaching overbought territory. Moving averages are converging, suggesting no strong directional trend. Key resistance levels are at R1: 17.359 and R2: 17.844, while support levels are at S1: 15.787 and S2: 15.301. Overall, the technical indicators do not provide a clear buy signal.

Positive Catalysts

  • Analysts highlight Jefferson Capital's low leverage, efficient collection model, and strong positioning in the U.S. market. Recent acquisitions and operational advantages are expected to drive medium-term outperformance. The selloff is viewed as an attractive entry point by some analysts.

Neutral/Negative Catalysts

  • No recent news or significant trading trends from insiders or hedge funds. The stock's short-term trend suggests a potential decline of -0.76% over the next week and -0.6% over the next month. Lack of financial data and valuation metrics limits deeper analysis.

Financial Performance

No financial data available for the latest quarter.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts maintain an Outperform rating with price targets of $21 and $28. They emphasize the company's operational strengths and medium-term growth potential, but no immediate catalysts are evident.

Wall Street analysts forecast JCAP stock price to rise
4 Analyst Rating
Wall Street analysts forecast JCAP stock price to rise
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 17.410
sliders
Low
26
Averages
27.25
High
29
Current: 17.410
sliders
Low
26
Averages
27.25
High
29
Raymond James
Outperform
to
Outperform
downgrade
$22 -> $21
AI Analysis
2026-05-15
Reason
Raymond James
Price Target
$22 -> $21
AI Analysis
2026-05-15
downgrade
Outperform
to
Outperform
Reason
Raymond James lowered the firm's price target on Jefferson Capital to $21 from $22 and keeps an Outperform rating on the shares. The company's lower leverage, efficient collection model, heavy exposure to the currently more attractive U.S. market, and recent acquisition position Jefferson Capital to outperform in the medium term, the analyst tells investors in a research note.
Keefe Bruyette
Outperform
maintain
$28
2026-03-30
Reason
Keefe Bruyette
Price Target
$28
2026-03-30
maintain
Outperform
Reason
Jefferson Capital's management, led by CEO David Burton and CFO Christo Realov, highlighted opportunities for capital deployment, historical outperformance in recessions, low leverage supporting increased deployment, and structural operational advantages over peers, positioning the company well to deliver on a strong operating outlook, Keefe Bruyette tells investors in a research note. The firm, which has an Outperform rating and $28 price target on the shares, says the selloff creates an attractive entry point.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for JCAP
Unlock Now

People Also Watch